COMPLETED

Recovery and Outcomes From Stroke

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators will perform follow-up on 500 cases of deep and lobar intracerebral hemorrhage to perform advanced neuroimaging before 45 days post stroke, and evaluations of motor and cognitive function at baseline, 3 months and 6 months to determine predictors of recovery, progressive cognitive or functional impairment.

Official Title

Recovery and Outcomes From Stroke (ROSE) Sub-study of Genetic and Environmental Risk Factors for Hemorrhagic Stroke

Quick Facts

Study Start:2017-08-23
Study Completion:2024-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04007757

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or greater, fulfillment of the criteria for Deep, Subcortical or Lobar Intracerebral Hemorrhage (ICH)
  2. * No evidence of trauma, vascular malformation or aneurysm, or brain tumor as a cause of ICH.
  3. * Ability of the patient or legal representative to provide informed consent
  1. * Brainstem or Cerebellar ICH
  2. * Patients Severely Affected by the ICH, Early Mortality, Hospice, or Withdraw of Care NOT eligible for ROSE

Contacts and Locations

Principal Investigator

Daniel Woo, MD, MS
PRINCIPAL_INVESTIGATOR
State University of New York at Buffalo

Study Locations (Sites)

University of Illinois Chicago
Chicago, Illinois, 60612
United States
Baptist Health Louisville
Louisville, Kentucky, 40207
United States
University of Maryland
Baltimore, Maryland, 21201
United States
Massachusetts General Hospital
Boston, Massachusetts, 02114
United States
Columbia University
New York, New York, 10032
United States
Duke University
Durham, North Carolina, 27710
United States
University of Cincinnati
Cincinnati, Ohio, 45267
United States
Houston Methodist
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: State University of New York at Buffalo

  • Daniel Woo, MD, MS, PRINCIPAL_INVESTIGATOR, State University of New York at Buffalo

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-08-23
Study Completion Date2024-10-31

Study Record Updates

Study Start Date2017-08-23
Study Completion Date2024-10-31

Terms related to this study

Keywords Provided by Researchers

  • Intracerebral Hemorrhage
  • Hemorrhagic Stroke
  • Intracerebral Hematoma

Additional Relevant MeSH Terms

  • Intracerebral Hemorrhage